CAR T cell activation is associated with a higher density of antigens on target cells.[17] To test whether increasing the density of small molecule antigens on tumor‐targeting antibodies affects FL‐CAR T cell activation, we conjugated anti‐EGFR antibodies with increasing amounts of fluorescein (Figure S4–S6, Table S1). This evidence concerns the gene EGFR and neoplasm.